revealed that circPARD3, a unique autophagy inhibitor, promotes the progression and chemoresistance of laryngeal squamous cell carcinoma via the PRKCI-Akt-mTOR axis. This evidence concerns the gene AKT1 and laryngeal squamous cell carcinoma.